Emcure Pharmaceuticals Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 1,963 | 2,116 | 2,101 | 2,270 | 2,363 | 2,470 | 2,580 | 2,820 | |
| 4 | 4 | 4 | 3 | 2 | 4 | 2 | 3 | |
| 1,737 | 1,850 | 1,810 | 1,932 | 2,013 | 2,143 | 2,189 | 2,378 | |
| 400 | 404 | 433 | 420 | 421 | 419 | 481 | 642 | |
| 429 | 572 | 550 | 625 | 560 | 661 | 555 | 625 | |
| −46 | −84 | −181 | −156 | −19 | −77 | 37 | −125 | |
| 367 | 373 | 393 | 385 | 387 | 387 | 410 | 435 | |
| 32 | 39 | 27 | 33 | 38 | 46 | 32 | 36 | |
| 97 | 97 | 99 | 105 | 105 | 106 | 110 | 110 | |
| 458 | 448 | 488 | 520 | 521 | 600 | 565 | 656 | |
| 359 | 396 | 417 | 479 | 456 | 494 | 535 | 591 | |
| 262 | 300 | 318 | 374 | 352 | 388 | 425 | 481 | |
| — | −10 | −4 | — | −38 | 10 | — | — | |
| 230 | 261 | 291 | 341 | 314 | 341 | 394 | 446 | |
| 74 | 63 | 76 | 90 | 82 | 97 | 101 | 121 | |
| 156 | 197 | 215 | 251 | 231 | 244 | 292 | 325 | |
| Financial ratios | ||||||||
| 18.27% | 18.73% | 19.85% | 21.09% | 19.31% | 20.00% | 20.72% | 20.96% | |
| 7.95% | 9.32% | 10.23% | 11.07% | 9.79% | 9.87% | 11.33% | 11.53% | |
| 8.12 | 9.97 | 10.92 | 12.85 | 12.16 | 12.84 | 15.50 | 17.16 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.